Cargando…
Atypical Femoral Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research
Bisphosphonate (BP) is a useful anti-resorptive agent which decreases the risk of osteoporotic fracture by about 50%. However, recent evidences have shown its strong correlation with the occurrence of atypical femoral fracture (AFF). The longer the patient takes BP, the higher the risk of AFF. Also,...
Autores principales: | Yang, Kyu Hyun, Min, Byung Woo, Ha, Yong-Chan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Bone and Mineral Research
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572036/ https://www.ncbi.nlm.nih.gov/pubmed/26389082 http://dx.doi.org/10.11005/jbm.2015.22.3.87 |
Ejemplares similares
-
Position Statement: Atypical Femoral Fracture from the Korean Society for Bone and Mineral Research in 2023
por: Nho, Jae-Hwi, et al.
Publicado: (2023) -
Osteoporotic Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research
por: Yoo, Je-Hyun, et al.
Publicado: (2015) -
Fracture Liaison Service in Korea: 2022 Position Statement of the Korean Society for Bone and Mineral Research
por: Lim, Jae-Young, et al.
Publicado: (2023) -
Calcium and Vitamin D Supplementations: 2015 Position Statement of the Korean Society for Bone and Mineral Research
por: Kim, Kyoung Min, et al.
Publicado: (2015) -
Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons
por: Kim, Kyoung Min, et al.
Publicado: (2015)